HWI group Revenue and Competitors

HWI group - an innovative and independent partner for pharma, medtech and biotech industries. HWI was founded in 1991 and has been further developing its range of services for active ingredients, medicinal products, medical devices and related products ever since. Today we offer our HWI services from our sites in Rülzheim (HWI pharma services GmbH), Appenweier (HWI development GmbH) and Planegg (HWI regulatory services GmbH). The HWI service portfolio ranges from analysis and quality control, active-?ingredient characterisation, product development, production of clinical samples and small batches, marketing authorisation, drug safety and GxP services. Together with our network partners, we offer clinical and preclinical investigations. We also supply high-?quality pharmaceutical reference substances with additional services such as user-?specific portioning, storage, monitoring and (just-?in-time) distribution. In addition to conventional services we are open to new and innovative models of collaboration with our customers, for example co-?developing medicinal products, independent complete life cycle support of products and product groups, and undertaking responsible tasks for our customers. Our aim is always to provide services that create the greatest possible value for our customers. Benefit from our interdisciplinary knowledge and our experience in analysis, development, production, marketing authorisations, clinical matters and drug safety. Use our network of experts and our effective and well-?coordinated team.